Ernexa Therapeutics Inc. Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31)
Ernexa Therapeutics Inc. (ERNA) reported Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) of $20.00 thousand for the 9-month period ending 2011-09-30, per its 10-Q filed 2012-11-09.
Discontinued › Income Statement › Other Income
us-gaap:AvailableForSaleSecuritiesChangeInNetUnrealizedHoldingGainLoss · last filed 2012-11-09
- Ernexa Therapeutics Inc. available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2011-09-30 was -$11.00K.
- Ernexa Therapeutics Inc. available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2011-06-30 was $57.00K.
- Ernexa Therapeutics Inc. available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2011-03-31 was -$26.00K.
- Ernexa Therapeutics Inc. available-for-sale securities, change in net unrealized holding gain (loss) before taxes (deprecated 2018-01-31) for the quarter ending 2010-09-30 was -$3.00K.
| Period end | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 3 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 6 month | Available-for-sale Securities, Change in Net Unrealized Holding Gain (Loss) before Taxes (Deprecated 2018-01-31) 9 month |
|---|---|---|---|
| 2011-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $46.00K derived: sum of 2 quarters · filed 2012-11-09 | $20.00K 10-Q · filed 2012-11-09 |
| 2011-06-30 | $57.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $31.00K 10-Q · filed 2012-08-14 | |
| 2011-03-31 | -$26.00K 10-Q · filed 2012-05-11 | ||
| 2010-09-30 | -$3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $15.00K 10-Q · filed 2011-11-14 | |
| 2010-06-30 | $18.00K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |